Rare Disease and Orphan Drugs Journal
All Journals
Search Log In
Home Articles Special Issues Volumes Webinars Videos
Rare Disease and Orphan Drugs Journal
Search Submit
Home Articles Special Issues Volumes Webinars Videos

fig2

From:  Non-viral gene therapy for neuromuscular diseases including Duchenne muscular dystrophy using nanovesicles derived from human cells
Non-viral gene therapy for neuromuscular diseases including Duchenne muscular dystrophy using nanovesicles derived from human cells

Figure 2. BioDrone® Platform Technology. (A) A schematic diagram shows the possible mechanism of the high productivity of CDVs compared to EVs (from Lau et al., 2022[106]). (B) Comparison of nanovesicle yield per unit cell between CDVs and EVs in diverse source cells.

Rare Disease and Orphan Drugs Journal
ISSN 2771-2893 (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://publicationethics.org/members/rare-disease-and-orphan-drugs-journal

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://publicationethics.org/members/rare-disease-and-orphan-drugs-journal

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2024 OAE Publishing Inc., except certain content provided by third parties